- Home
- LITE vs IKT Comparison
LITE vs IKT Comparison
Compare LITE & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITE
- IKT
- Stock Information
- Founded
- LITE 2015
- IKT 2008
- Country
- LITE United States
- IKT United States
- Employees
- LITE N/A
- IKT N/A
- Industry
- LITE Telecommunications Equipment
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- LITE Telecommunications
- IKT Health Care
- Exchange
- LITE Nasdaq
- IKT Nasdaq
- Market Cap
- LITE 5.7B
- IKT 131.6M
- IPO Year
- LITE N/A
- IKT 2020
- Fundamental
- Price
- LITE $91.24
- IKT $1.85
- Analyst Decision
- LITE Buy
- IKT Buy
- Analyst Count
- LITE 15
- IKT 2
- Target Price
- LITE $82.47
- IKT $8.00
- AVG Volume (30 Days)
- LITE 2.3M
- IKT 519.6K
- Earning Date
- LITE 08-13-2025
- IKT 08-13-2025
- Dividend Yield
- LITE N/A
- IKT N/A
- EPS Growth
- LITE N/A
- IKT N/A
- EPS
- LITE N/A
- IKT N/A
- Revenue
- LITE $1,472,600,000.00
- IKT N/A
- Revenue This Year
- LITE $21.98
- IKT N/A
- Revenue Next Year
- LITE $31.42
- IKT N/A
- P/E Ratio
- LITE N/A
- IKT N/A
- Revenue Growth
- LITE 3.58
- IKT N/A
- 52 Week Low
- LITE $38.29
- IKT $1.12
- 52 Week High
- LITE $104.00
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- LITE 65.12
- IKT 49.70
- Support Level
- LITE $86.63
- IKT $1.56
- Resistance Level
- LITE $96.68
- IKT $2.04
- Average True Range (ATR)
- LITE 3.23
- IKT 0.15
- MACD
- LITE -0.10
- IKT 0.02
- Stochastic Oscillator
- LITE 63.12
- IKT 61.05
About LITE Lumentum Holdings Inc.
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.